Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W E Hardman

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Nutrition and Cancer|January 1, 1997
The nonfermentable dietary fiber lignin alters putative colon cancer risk factors but does not protect against DMH-induced colon cancer in ratsI L Cameron, W E Hardman, D W Heitman
Cell Proliferation|August 1, 1996
Aspirin suppresses 1,2-dimethylhydrazine-induced alteration of proliferative parameters in rat colonic cryptsC J Barnes, M Lee, W E Hardman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 breast cancer xenograftsW E Hardman, C P Avula, G Fernandes, et al.
Cell Proliferation|February 1, 1995
Aspirin, age, and proximity to lymphoid nodules influence cell proliferation parameters in rat colonic cryptsC J Barnes, M Lee, W E Hardman, et al.
Digestive Diseases and Sciences|May 1, 1997
Aspirin, but not sodium salicylate, indomethacin, or nabumetone, reversibly suppresses 1,2-dimethylhydrazine-induced colonic aberrant crypt foci in ratsC J Barnes, W E Hardman, I L Cameron, et al.
Nutrition and Cancer|January 1, 1997
Zinc deprivation promotes progression of 1,2-dimethylhydrazine-induced colon tumors but reduces malignant invasion in miceJ W Carter, H Lancaster, W E Hardman, et al.
Cancer Research|December 1, 1991
Demonstration of the need for end point validation of putative biomarkers: failure of aberrant crypt foci to predict colon cancer incidenceW E Hardman, I L Cameron, D W Heitman, et al.
British Journal of Cancer|March 4, 1998
Non-steroidol anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesisC J Barnes, I L Cameron, W E Hardman, et al.
Cell Proliferation|December 2, 2000
Dietary fibre on cell proliferation in large bowel mucosal crypts near or away from lymphoid nodules and on mineral bioavailabilityI L Cameron, W E Hardman, D W Heitman, et al.
Cancer Research|August 15, 1994
Distribution of intestine-associated lymphoid tissue, aberrant crypt foci, and tumors in the large bowel of 1,2-dimethylhydrazine-treated miceJ W Carter, H K Lancaster, W E Hardman, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Nutrition and Cancer|January 1, 1997
The nonfermentable dietary fiber lignin alters putative colon cancer risk factors but does not protect against DMH-induced colon cancer in ratsI L Cameron, W E Hardman, D W Heitman
Cell Proliferation|August 1, 1996
Aspirin suppresses 1,2-dimethylhydrazine-induced alteration of proliferative parameters in rat colonic cryptsC J Barnes, M Lee, W E Hardman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 breast cancer xenograftsW E Hardman, C P Avula, G Fernandes, et al.
Cell Proliferation|February 1, 1995
Aspirin, age, and proximity to lymphoid nodules influence cell proliferation parameters in rat colonic cryptsC J Barnes, M Lee, W E Hardman, et al.
Digestive Diseases and Sciences|May 1, 1997
Aspirin, but not sodium salicylate, indomethacin, or nabumetone, reversibly suppresses 1,2-dimethylhydrazine-induced colonic aberrant crypt foci in ratsC J Barnes, W E Hardman, I L Cameron, et al.
Nutrition and Cancer|January 1, 1997
Zinc deprivation promotes progression of 1,2-dimethylhydrazine-induced colon tumors but reduces malignant invasion in miceJ W Carter, H Lancaster, W E Hardman, et al.
Cancer Research|December 1, 1991
Demonstration of the need for end point validation of putative biomarkers: failure of aberrant crypt foci to predict colon cancer incidenceW E Hardman, I L Cameron, D W Heitman, et al.
British Journal of Cancer|March 4, 1998
Non-steroidol anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesisC J Barnes, I L Cameron, W E Hardman, et al.
Cell Proliferation|December 2, 2000
Dietary fibre on cell proliferation in large bowel mucosal crypts near or away from lymphoid nodules and on mineral bioavailabilityI L Cameron, W E Hardman, D W Heitman, et al.
Cancer Research|August 15, 1994
Distribution of intestine-associated lymphoid tissue, aberrant crypt foci, and tumors in the large bowel of 1,2-dimethylhydrazine-treated miceJ W Carter, H K Lancaster, W E Hardman, et al.
Pageof 3